Epigenetic silencing of microRNA-203 dysregulates ABL1 expression and drives Helicobacter-associated gastric lymphomagenesis.

Gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) develops in the chronically inflamed mucosa of patients infected with the bacterial pathogen Helicobacter pylori. Here we use patient material, primary gastric lymphoma cell cultures, and a preclinical model of the disease to examine the role of microRNA (miRNA)-mediated posttranscriptional regulation--focusing in particular on miR-203 and its target ABL1--in gastric MALT lymphomagenesis. Microarray-based miRNA expression profiling revealed a strong downregulation of the putative tumor suppressor miRNA miR-203 in human MALT lymphoma samples, which resulted from extensive promoter hypermethylation of the miR-203 locus and coincided with the dysregulation of the miR-203 target ABL1 in lymphoma biopsies compared with matched adjacent normal material from the same patients. Treatment of lymphoma B cells with demethylating agents led to increased miR-203 expression and the concomitant downregulation of ABL1, confirming the epigenetic regulation of this miRNA. Ectopic reexpression of miR-203 by transfection of a human lymphoma cell line or lentiviral transduction of explanted primary MALT lymphoma cells was sufficient to prevent tumor cell proliferation in vitro. Similarly, the treatment of primary MALT lymphoma cells with the ABL inhibitors imatinib and dasatinib prevented tumor cell growth. Finally, we show that the treatment of tumor-bearing mice with imatinib induces MALT lymphoma regression in a preclinical model of the disease, implicating ABL1 in MALT lymphoma progression. In summary, our results show that the transformation from gastritis to MALT lymphoma is epigenetically regulated by miR-203 promoter methylation and identify ABL1 as a novel target for the treatment of this malignancy.

[1]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[2]  C. Geary Leukemia , 1984, British Journal of Cancer.

[3]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[4]  S. Goff,et al.  Mice homozygous for the abl m1 mutation show poor viability and depletion of selected B and T cell populations , 1991, Cell.

[5]  M. Stolte,et al.  Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  A. Chadli THE CANCER CELL , 1924, La Presse medicale.

[7]  C. Croce,et al.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  A. Rosenwald,et al.  Expression of costimulatory molecules in low-grade mucosa-associated lymphoid tissue-type lymphomas in vivo. , 1999, The American journal of pathology.

[9]  C. Thieblemont Clinical presentation and management of marginal zone lymphomas. , 2005, Hematology. American Society of Hematology. Education Program.

[10]  P. Zipfel,et al.  The c-Abl Tyrosine Kinase Is Regulated Downstream of the B Cell Antigen Receptor and Interacts with CD191 , 2000, The Journal of Immunology.

[11]  S. Cogliatti,et al.  B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis , 2010, Leukemia.

[12]  T. C. Diss,et al.  Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori , 1993, The Lancet.

[13]  R. Stephens,et al.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.

[14]  A. Lee,et al.  MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. A mouse model of Helicobacter pylori-induced gastric lymphoma. , 1995, The American journal of pathology.

[15]  R. Knight,et al.  miR-203 represses ‘stemness’ by repressing ΔNp63 , 2008, Cell Death and Differentiation.

[16]  S. Falkow,et al.  Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins. , 2010, Blood.

[17]  M. Byrom,et al.  Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.

[18]  Shinji Tanaka,et al.  miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. , 2010, Carcinogenesis.

[19]  Muller Fabbri,et al.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.

[20]  S. Falkow,et al.  Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Stolte,et al.  Expression profiling reveals specific gene expression signatures in gastric MALT lymphomas , 2008, Leukemia & lymphoma.

[22]  L. E. McDonald,et al.  A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Falkow,et al.  The role of antigenic drive and tumor-infiltrating accessory cells in the pathogenesis of helicobacter-induced mucosa-associated lymphoid tissue lymphoma. , 2005, The American journal of pathology.

[24]  O. Ottmann,et al.  Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. , 2005, Hematology. American Society of Hematology. Education Program.

[25]  J. Cigudosa,et al.  Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. , 2008, Cancer cell.

[26]  M. Stolte,et al.  Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series , 2003, Gut.

[27]  F. Cavalli,et al.  Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. , 2002, Blood.

[28]  K. Kosik,et al.  Activation of the neuronal c-Abl tyrosine kinase by amyloid-β-peptide and reactive oxygen species , 2004, Neurobiology of Disease.

[29]  J. Cawley,et al.  c-Abl expression in chronic lymphocytic leukemia cells: clinical and therapeutic implications. , 2006, Cancer research.

[30]  T. Hirayama,et al.  MicroRNA signatures in Helicobacter pylori‐infected gastric mucosa , 2011, International journal of cancer.

[31]  R. Berger,et al.  Variant translocation in a non endemic case of Burkitt's lymphoma: t (8;22) in an Epstein--Barr virus negative tumour and in a derived cell line. , 1981, European journal of cancer.

[32]  M. Ehrlich,et al.  ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors. , 2001, Cancer research.

[33]  A. Lee,et al.  Antigen-dependent progression of mucosa-associated lymphoid tissue (MALT)-type lymphoma in the stomach. Effects of antimicrobial therapy on gastric MALT lymphoma in mice. , 1998, The American journal of pathology.

[34]  J. Baselga,et al.  Targeting Tyrosine Kinases in Cancer: The Second Wave , 2006, Science.

[35]  Kathryn A. O’Donnell,et al.  c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.

[36]  V. Ambros The functions of animal microRNAs , 2004, Nature.

[37]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[38]  E. Zucca,et al.  State-of-the-art therapeutics: marginal-zone lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  Laura Pelletier,et al.  MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations , 2008, Hepatology.

[40]  松島 加代子 MicroRNA signatures in Helicobacter pylori-infected gastric mucosa , 2010 .

[41]  Jason H. Moore,et al.  Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. , 2007, Cancer research.

[42]  Ming-Qing Du,et al.  MALT lymphoma: from morphology to molecules , 2004, Nature Reviews Cancer.